$CTY

$19.09▲ -0.1% YTD

4 SEC 13D/G filings tracked · Last updated Nov 4, 2026

Filing History

CP $19.09▲ -0.1%Nov 4, 2026 · ThinkSabio Blog

$CTY - Phase 1 Data for CITY-FXI, an RNAi Therapeutic Candidate for Thromboembolic Diseases, Selected for Oral Presentation at the 68th ASH Annual Mee…

News

CTY ▲ +0.9% - City Therapeutics, Inc.

CP $20.88▲ +0.9%Nov 3, 2026 · ThinkSabio Blog

$CTY - City Therapeutics to Present at Upcoming November Investor Conferences…

News

CTY ▼ -4.2% - City Therapeutics, Inc.

CP $21.46▲ -4.2%Oct 19, 2026 · ThinkSabio Blog

$CTY - City Therapeutics Announces Closing of $230.0 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purch…

News

CTY ▲ +0.0% - City Therapeutics, Inc. Common Stock

CP $25.05▲ +0.0%Oct 16, 2026 · ThinkSabio Blog

$CTY - City Therapeutics Announces Pricing of Upsized Initial Public Offering…